1. Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece. (17th February 2022) Authors: Gourzoulidis, George; Koulentaki, Maria; Koumarianou, Anna; Samadas, Epaminondas; Androulakis, Nikolaos; Xynogalos, Spyridon; Papakotoulas, Pavlos; Boukovinas, Ioannis; Karamouzis, Michalis; Souglakos, John; Chotzagiannoglou, Vasiliki; Beletsi, Alexandra; Kourlaba, Georgia Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 22:Number 2(2022) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗